Browse the evidence

GLP-1ra users have similar postoperative outcomes following body contouring surgery compared to non-GLP-1ra controls.

Practitioners can consider GLP-1ra use as not adversely affecting postoperative outcomes in body contouring surgeries.

Postoperative cellulitis occurred less frequently among GLP-1ra users in matched cohorts.

GLP-1ra use may be associated with a lower risk of postoperative cellulitis.

Wound dehiscence is more prevalent among patients taking GLP-1ras for diabetes compared to those using it for weight loss.

Consideration of the indication for GLP-1ra use may be important in assessing surgical risk.

One-year discontinuation rates for GLP-1 receptor agonists can be as high as 74% in real-world studies.

Healthcare providers should be aware of the high discontinuation rates of GLP-1 RAs in real-world settings.

The distribution of protein intake (balanced vs unbalanced) did not influence myofibrillar protein synthesis rates.

The timing and distribution of protein intake may not be critical for maximizing muscle protein synthesis in young adults.

The percent kilocalories from carbohydrate was higher in the omnivorous group compared to the vegan group.

Omnivorous diets may provide a higher carbohydrate intake compared to vegan diets, which could influence overall energy balance.

The goal-achievement rate for glycaemic control decreased from 54.8% after 1 year of treatment to 19.4% 5 years later.

Practitioners should be aware that long-term glycaemic control may significantly decline.

The coefficient of failure (CoF) for glycaemic control was 0.123 ± 0.022%/year overall, with variations based on weight change.

Understanding the CoF can help in assessing long-term treatment effectiveness.

Mean weight loss at 6 months was 1.08 kg for intervention subjects and 1.35 kg among controls.

Both intervention and control groups experienced weight loss, but the difference was not significant.

The hamstrings, iliopsoas, adductors, and tibialis anterior produced the largest downward acceleration about the center of mass.

Understanding these muscle contributions can help in designing rehabilitation programs focusing on these muscle groups.

Incretin combination therapies are being developed for the treatment of nonalcoholic fatty liver disease (NAFLD) in patients with diabetes.

Practitioners should consider the potential of incretin therapies for managing NAFLD in diabetic patients.

Decisions about what we buy are heavily influenced by the food industry, government policies, and personal beliefs about food.

Practitioners should consider the impact of external influences on clients' food choices.

Most people's beliefs and behaviors about nutrition are influenced by governmental nutritional policy.

Nutrition policies should be considered when developing public health strategies.

A nutritionist’s viewpoint is expected to be governed largely by objective, peer-reviewed science.

Practitioners should emphasize evidence-based practices in nutrition counseling.

Obesity rates are high in high-income countries and are rapidly increasing in low- and middle-income countries.

Public health initiatives should focus on addressing obesity in both high-income and low-income countries.

The global consumption of unhealthy products, such as soft drinks and processed foods, continues to rise.

Efforts to promote healthier eating habits must address the rising consumption of unhealthy products.

The expansion of multinational food and beverage companies, or ‘Big Food’, is a key factor behind rising obesity rates and unhealthy consumption.

Regulatory measures may be needed to address the influence of 'Big Food' on public health.

The type of muscular contraction (eccentric or concentric) does not affect muscle protein FSR.

Practitioners can choose either contraction type without concern for differences in muscle protein synthesis outcomes.

There were no statistically significant differences in metabolic adaptations for 24 h, sleep, or resting expenditures.

This suggests that exercise may not lead to significant changes in metabolic rates during rest or sleep.

Reduction in HbA1c was not significantly different between the high- and low-dose intervention.

Both high and low doses of produce prescriptions may be equally effective for HbA1c reduction.

GIP receptor-modulating medications may cause weight loss.

GIP receptor-modulating therapies may be considered for obesity treatment, but further research is needed.

Diabetes mellitus is associated with nutritional and metabolic derangements that are often neglected in clinical assessments.

Healthcare professionals should prioritize nutritional assessments in diabetes management.

Sarcopenic diabetes is recognized as a distinct clinical condition that requires more awareness and research.

There is a need for increased focus on sarcopenic diabetes in clinical practice and research.

L-aspartate administration led to a significant reduction in body weight, with decreases of 14.5% in HFC diet mice and 8.5% in HFC diet-induced obese mice.

L-aspartate may be considered as a potential treatment for obesity in similar dietary contexts.